Evidence map›Paper›PMID 18474526›Full record

ArticleNucleic acids research2008

Assessment of gene expression in many samples using vertical arrays.

Rosa Ana Risques, Gaelle Rondeau, Martin Judex, Michael McClelland, John Welsh

Abstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rosa Ana RisquesSidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA 92121, USA.
Gaelle Rondeau
Martin Judex
Michael McClelland
John Welsh

Funding

RNA FINGERPRINTING USING ARBITRARILY PRIMED PCRR01CA068822 · NCI · VACCINE RESEARCH INSTITUTE OF SAN DIEGO · PI MCCLELLAND, MICHAEL · 1995 to 2008
$2.8M
Cancer Vertical ArraysR21CA116214 · NCI · SIDNEY KIMMEL CANCER CENTER · PI WELSH, JOHN T · 2006 to 2007
$471k
NCI NIH HHS CA068822NCI NIH HHS CA116214NCI NIH HHS R01 CA068822NCI NIH HHS R21 CA116214
6 · The paper itself

Abstract

Microarrays and high-throughput sequencing methods can be used to measure the expression of thousands of genes in a biological sample in a few days, whereas PCR-based methods can be used to measure the expression of a few genes in thousands of samples in about the same amount of time. These methods become more costly as the number of biological samples increases or as the number of genes of interest increases, respectively, and these factors constrain experimental design. To address these issues, we introduced 'vertical arrays' in which RNA from each biological sample is converted into multiple, overlapping cDNA subsets and spotted on glass slides. These vertical arrays can be queried with single gene probes to assess the expression behavior in thousands of biological samples in a single hybridization reaction. The spotted subsets are less complex than the original RNA from which they derive, which improves signal-to-noise ratios. Here, we demonstrate the quantitative capabilities of vertical arrays, including the sensitivity and accuracy of the method and the number of subsets needed to achieve this accuracy for most expressed genes.

Indexed as

Cell LineGene Expression ProfilingGene Expression RegulationHumansOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Messenger

Identifiers

PMID18474526
PMCPMC2425485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.